<DOC>
	<DOC>NCT01349712</DOC>
	<brief_summary>The purpose of this study is to measure prothrombin time (PT) on an experimental device and a commercially available device on persons receiving coumadin (warfarin)treatment.</brief_summary>
	<brief_title>Study to Test the Accuracy of a Prototype Handheld PT/INR Device</brief_title>
	<detailed_description>This study will require participants to have up to 2 finger-punctures taken and sample tested on a strip and meter system for both the experimental and commercially available devices.</detailed_description>
	<mesh_term>Blood Coagulation Disorders</mesh_term>
	<mesh_term>Hemostatic Disorders</mesh_term>
	<criteria>Currently taking coumadin (warfarin) Aged 18 years or older Able and willing to provide informed consent Can understand (read and write) English</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2011</verification_date>
</DOC>